Stimcell Energetics (STME) Cash & Equivalents (QoQ) (2016 - 2026)
Stimcell Energetics (STME) Cash & Equivalents (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -77.78% |
| Nov 30, 2025 | 617.09% |
| Aug 31, 2025 | -55.85% |
| May 31, 2025 | 118.34% |
| Feb 28, 2025 | -80.25% |
| Nov 30, 2024 | 64.56% |
| Aug 31, 2024 | -52.66% |
| May 31, 2024 | -45.51% |
| Feb 29, 2024 | 252.19% |
| Nov 30, 2023 | -61.04% |
| Aug 31, 2023 | -40.92% |
| May 31, 2023 | 1,188.61% |
| Feb 28, 2023 | -57.18% |
| Nov 30, 2022 | 85.17% |
| Aug 31, 2022 | -60.54% |
| May 31, 2022 | -20.68% |
| Feb 28, 2022 | -17.26% |
| Nov 30, 2021 | -41.75% |
| Aug 31, 2021 | 207.29% |
| May 31, 2021 | -20.08% |